Investigating the performance of the sustainable cold supply chain in the pharmaceutical industry

Loading...
Publication Logo

Date

2022

Authors

Cansu Turan
Yucel Yilmaz Ozturkoglu

Journal Title

Journal ISSN

Volume Title

Publisher

Emerald Group Holdings Ltd.

Open Access Color

Green Open Access

No

OpenAIRE Downloads

OpenAIRE Views

Publicly Funded

No
Impulse
Top 10%
Influence
Average
Popularity
Top 10%

Research Projects

Journal Issue

Abstract

Purpose: This study focuses on identifying potential challengers affecting cold chain performance in the pharmaceutical industry. Considering the history of humanity every pandemic experienced could only be controlled with the vaccine found. While the world is fighting the unforgettable epidemic called COVID-19 scientists are also working to find the therapeutic vaccine. The vaccines studied have different temperature storage and transport properties. In the pharmaceutical industry it is necessary to know and analyse every step of the cold supply chain to provide the most appropriate and safe cooling level. In addition it is important to understand the relationship between all the facilities equipment tools and materials needed to avoid mistakes along the chain. Design/methodology/approach: Hence this study focuses on identifying potential challengers affecting sustainable cold supply chain performance in the pharmaceutical industry and proposing a conceptual framework that involves these main challengers. In this study firstly different main and sub-factors are defined from the literature and fuzzy Decision Making Trial and Evaluation Laboratory method is applied to analyse the causal link between these factors for an effective application. Findings: Results showed that packaging transportation and shipping storage specifications and handling practices inventory management technical issues and delivery delay are the most affected factors during the sustainable cold supply chain performance in the pharmaceutical industry. This study offers both managerial implications and a roadmap that are designed with a holistic view to guide manufacturer logistics parties and even policymakers. Originality/value: Some of the studies related to the pharmaceutical industry are monitoring and controlling the temperature in the cold supply chain steps, the other part is the studies where the chain steps are examined with a focus on production or transportation. While these issues are the focus the requirements and conditions of each stage of the supply chain must be studied for a safe effective and sustainable cold chain beyond the current global pandemic crisis. To the best of the authors’ knowledge this is the first study that highlights identifying the potential challengers that affect cold supply chain performance for the pharmaceutical industry both theoretically and empirically solving the causal relationships among these challengers and designing a holistic framework. © 2022 Elsevier B.V. All rights reserved.

Description

Keywords

Cold Supply Chain, Fuzzy Dematel, Multi-criteria Decision Making, Pharmaceutical Industry, Pharmaceutical Industry, Cold Supply Chain, Fuzzy DEMATEL, Multi-Criteria Decision Making

Fields of Science

03 medical and health sciences, 0302 clinical medicine, 0502 economics and business, 05 social sciences

Citation

WoS Q

Scopus Q

OpenCitations Logo
OpenCitations Citation Count
13

Source

International Journal of Pharmaceutical and Healthcare Marketing

Volume

16

Issue

3

Start Page

448

End Page

467
PlumX Metrics
Citations

CrossRef : 12

Scopus : 16

Captures

Mendeley Readers : 98

Google Scholar Logo
Google Scholar™
OpenAlex Logo
OpenAlex FWCI
2.6041

Sustainable Development Goals